BG64448B1 - 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them - Google Patents

1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them Download PDF

Info

Publication number
BG64448B1
BG64448B1 BG104112A BG10411200A BG64448B1 BG 64448 B1 BG64448 B1 BG 64448B1 BG 104112 A BG104112 A BG 104112A BG 10411200 A BG10411200 A BG 10411200A BG 64448 B1 BG64448 B1 BG 64448B1
Authority
BG
Bulgaria
Prior art keywords
group
alkyl
phenyl
pyrido
formula
Prior art date
Application number
BG104112A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG104112A (en
Inventor
Ferrer Jordi Gracia
Crespo Ma Isabel Crespo
Noverola Armando Vega
Garcia Andres Fernandez
Original Assignee
Almirall Prodesfarma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma Sa filed Critical Almirall Prodesfarma Sa
Publication of BG104112A publication Critical patent/BG104112A/xx
Publication of BG64448B1 publication Critical patent/BG64448B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG104112A 1997-07-29 2000-01-27 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them BG64448B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701670A ES2137113B1 (es) 1997-07-29 1997-07-29 Nuevos derivados de triazolo-piridazinas heterociclicos.

Publications (2)

Publication Number Publication Date
BG104112A BG104112A (en) 2001-01-31
BG64448B1 true BG64448B1 (en) 2005-02-28

Family

ID=8300216

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104112A BG64448B1 (en) 1997-07-29 2000-01-27 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them

Country Status (36)

Country Link
US (2) US6407108B1 (pt)
EP (1) EP1001955B1 (pt)
JP (1) JP4320118B2 (pt)
KR (1) KR20010022353A (pt)
CN (1) CN1135231C (pt)
AR (1) AR015927A1 (pt)
AT (1) ATE207069T1 (pt)
AU (1) AU737709B2 (pt)
BG (1) BG64448B1 (pt)
BR (1) BR9810829B1 (pt)
CA (1) CA2298935A1 (pt)
CO (1) CO4970780A1 (pt)
CZ (1) CZ290208B6 (pt)
DE (1) DE69802100T2 (pt)
DK (1) DK1001955T3 (pt)
EE (1) EE04313B1 (pt)
EG (1) EG24041A (pt)
ES (2) ES2137113B1 (pt)
HK (1) HK1024914A1 (pt)
HU (1) HUP0004708A3 (pt)
ID (1) ID24506A (pt)
IL (1) IL134081A (pt)
MY (1) MY118796A (pt)
NO (1) NO315118B1 (pt)
NZ (1) NZ502356A (pt)
PE (1) PE111099A1 (pt)
PL (1) PL191031B1 (pt)
PT (1) PT1001955E (pt)
RU (1) RU2202552C2 (pt)
SI (1) SI1001955T1 (pt)
SK (1) SK284046B6 (pt)
TR (1) TR200000243T2 (pt)
TW (1) TW542837B (pt)
UA (1) UA60339C2 (pt)
WO (1) WO1999006404A1 (pt)
ZA (1) ZA986248B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013953A2 (en) 1999-08-21 2001-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
FR2792938B1 (fr) * 1999-04-28 2001-07-06 Warner Lambert Co NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
WO2002080974A1 (fr) * 2001-04-04 2002-10-17 Sankyo Company, Limited Utilisation medicale d'inhibiteur de production de cytokine
DE60218497T2 (de) 2001-09-19 2007-11-08 Nycomed Gmbh Kombination eines nsaids und eines pde-4 inhibitors
FR2832711B1 (fr) * 2001-11-26 2004-01-30 Warner Lambert Co Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
WO2004041819A1 (ja) * 2002-11-06 2004-05-21 Grelan Pharmaceutical Co., Ltd. ピラゾロナフチリジン誘導体
ES2211344B1 (es) 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
RU2246496C1 (ru) * 2003-09-12 2005-02-20 Тец Виктор Вениаминович Вещество с противовирусной и антибактериальной активностью на основе производных 2,8-дитиоксо-1h-пирано[2,3-d, 6,5-d`] дипиримидина и их 10-аза-аналогов
ES2251866B1 (es) 2004-06-18 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
MX2007015578A (es) * 2005-06-10 2008-03-06 Merck & Co Inc Inhibidores de la actividad akt.
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
AU2006289838B2 (en) 2005-09-15 2011-08-18 Aska Pharmaceutical Co., Ltd. Heterocyclic compound, and production process and use thereof
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
EP2057164A1 (en) 2006-08-07 2009-05-13 Incyte Corporation Triazolotriazines as kinase inhibitors
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
ME01507B (me) 2006-11-22 2014-04-20 Incyte Holdings Corp Imidazotriazini i imidazopirimidini kao inhibitori kinaze
US20110112079A1 (en) * 2008-01-09 2011-05-12 Thomas Craig J Phosphodiesterase inhibitors
BRPI0912882A2 (pt) 2008-05-21 2017-05-16 Incyte Corp sais de 2-flúor-n-metil-4-[7-(quinolin-6-il-metil)-imidazo[1,2-b][1,2,4]triazin-2-il]benzamida e processos relacionados à preparação dos mesmos
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2226323A1 (en) 2009-02-27 2010-09-08 Almirall, S.A. New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
CA2786002C (en) 2009-12-31 2018-10-02 Joaquin Pastor Fernandez Tricyclic compounds for use as kinase inhibitors
WO2011162835A1 (en) 2010-02-03 2011-12-29 Incyte Corporation Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
EP2380890A1 (en) 2010-04-23 2011-10-26 Almirall, S.A. New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
EP2394998A1 (en) 2010-05-31 2011-12-14 Almirall, S.A. 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
WO2012098387A1 (en) 2011-01-18 2012-07-26 Centro Nacional De Investigaciones Oncológicas (Cnio) 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
WO2013005057A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) New compounds
WO2013005041A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) Tricyclic heterocyclic compounds as kinase inhibitors
WO2013004984A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncologicas (Cnio) Tricyclic compounds for use as kinase inhibitors
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085840A1 (en) * 1982-01-18 1983-08-17 Gruppo Lepetit S.P.A. New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3122670A1 (de) 1981-06-06 1982-12-23 Dr. Karl Thomae Gmbh, 7950 Biberach "neue 1,4,9,10-tetrahydro-pyrazolo(4,3-e) pyrido(3,2-b)(1,4)diazepin-10-one, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von pharmazeutischen wirkstoffen"
WO1991012251A1 (en) * 1990-02-19 1991-08-22 Chugai Seiyaku Kabushiki Kaisha Novel fused heterocyclic compound and antiasthmatic agent prepared therefrom
IL103388A (en) * 1991-10-09 1997-09-30 Syntex Inc PYRIDO £2,3-d| PYRIDAZINONES AND PYRIDAZINETHIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB9514465D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085840A1 (en) * 1982-01-18 1983-08-17 Gruppo Lepetit S.P.A. New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives

Also Published As

Publication number Publication date
ATE207069T1 (de) 2001-11-15
NO20000394L (no) 2000-03-27
HUP0004708A2 (hu) 2001-07-30
PL191031B1 (pl) 2006-03-31
AU8861298A (en) 1999-02-22
CZ2000333A3 (cs) 2000-05-17
CN1135231C (zh) 2004-01-21
EE200000052A (et) 2000-10-16
EG24041A (en) 2008-04-03
US6407108B1 (en) 2002-06-18
ES2162466T3 (es) 2001-12-16
UA60339C2 (uk) 2003-10-15
ZA986248B (en) 1999-02-05
CZ290208B6 (cs) 2002-06-12
EE04313B1 (et) 2004-06-15
BR9810829B1 (pt) 2009-08-11
NO315118B1 (no) 2003-07-14
JP2001512121A (ja) 2001-08-21
NZ502356A (en) 2001-03-30
SK862000A3 (en) 2000-07-11
EP1001955B1 (en) 2001-10-17
EP1001955A1 (en) 2000-05-24
AR015927A1 (es) 2001-05-30
DE69802100T2 (de) 2002-03-14
ES2137113B1 (es) 2000-09-16
PE111099A1 (es) 1999-11-18
BG104112A (en) 2001-01-31
KR20010022353A (ko) 2001-03-15
BR9810829A (pt) 2000-07-25
HK1024914A1 (en) 2000-10-27
RU2202552C2 (ru) 2003-04-20
AU737709B2 (en) 2001-08-30
IL134081A0 (en) 2001-04-30
CO4970780A1 (es) 2000-11-07
TW542837B (en) 2003-07-21
PT1001955E (pt) 2002-02-28
SK284046B6 (sk) 2004-08-03
DE69802100D1 (de) 2001-11-22
ID24506A (id) 2000-07-20
US20020183326A1 (en) 2002-12-05
SI1001955T1 (en) 2002-02-28
IL134081A (en) 2004-02-08
ES2137113A1 (es) 1999-12-01
CN1266434A (zh) 2000-09-13
CA2298935A1 (en) 1999-02-11
TR200000243T2 (tr) 2000-07-21
NO20000394D0 (no) 2000-01-26
WO1999006404A1 (en) 1999-02-11
DK1001955T3 (da) 2001-11-19
PL338214A1 (en) 2000-10-09
HUP0004708A3 (en) 2002-11-28
MY118796A (en) 2005-01-31
JP4320118B2 (ja) 2009-08-26

Similar Documents

Publication Publication Date Title
BG64448B1 (en) 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them
CA2382919C (en) Bicyclic imidazo-3-yl-amine derivatives
AU702548B2 (en) Chemical compounds
JP2002524564A (ja) ｃＧＭＰホスホジエステラーゼ阻害剤としてのカルボリン誘導体
EP0692483A1 (en) Cell adhesion inhibitor and thienotriazolodiazepine compound
CZ211696A3 (en) Tetracyclic derivatives, processes of their preparation, their use and pharmaceutical compositions containing thereof
EP0640606A1 (en) Thienopyrimidine derivatives, their production and use
TW200300344A (en) Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing them, method of preparation and use
JP2008521854A (ja) 新規ピリドチエノピリミジン誘導体
CZ265498A3 (cs) Triazolové deriváty, způsob jejich výroby a farmaceutický prostředek s jejich obsahem
SK1052000A3 (en) 3-substituted 3,4,5,7-tetrahydro-pyrrolo[3',4':4,5]thieno[2,3-d] pyrimidine derivatives, their preparation and use as 5ht antagonists
AU2003242737B2 (en) Pyrazoloisoquinoline derivatives for inhibiting NFkappaB-inducing kinase (NIK)
JPH0344392A (ja) ４Ｈ‐インドロ〔１，２‐ｄ〕〔１，２，４〕トリアゾロ〔４，３‐ａ〕〔１，４〕ベンゾジアゼピンおよびその製造法
MXPA00000910A (en) 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them
US3468897A (en) Certain 6-amino-2-(aryl or heteroaryl)-4-chromanone-hydrazones and derivatives
WO1999043679A1 (fr) Derives d'imidazoquinazoline
US3467673A (en) Octahydro-5h-1-benzazepin-5-one,cyclic ethylene ketals
Nicely et al. One-Pot Two-Step Catalytic Synthesis of Rationally Designed 6-amino-2-pyridone-3, 5-dicarbonitriles Enabling Anti-Cancer Bioactivity
CN117964639A (zh) 一种含苯并杂环结构的哒嗪类化合物、其药物组合物和用途
JP2004505980A (ja) ピロロトリアゾロピリミジノン誘導体
MXPA99010621A (en) 3-substituted pyrido [3',4':4,5]thieno [2,3-d]pyrimidine derivatives, and production and use of the same
JPH04334371A (ja) ベンズアゼピノピリダジン化合物
MXPA00001119A (en) 3-substituted 3,4,5,7-tetrahydro-pyrrolo3',4':4,5 thieno2,3-dpyrimidine derivatives, their preparation and use as 5ht antagonists